期刊文献+

杭州地区个体从业人员亚临床甲状腺功能减退症的调查分析

Screening analysis for subclincal hyPOthyroidism in independent merchant
原文传递
导出
摘要 目的:了解个体从业健康体检人员亚临床甲状腺功能减退症(SCH)的检出率,并观察SCH血清促甲状腺激素(TSH)与血脂的关系。方法:选取2007年个体从业健康体检人员血清2958份,采用化学免疫分析法测定TSH、游离三碘甲状腺原氨酸(FT3)和游离四碘甲状腺原氨酸(FT4)。血生化指标采用全自动生化检测仪测定。结果:2958例SCH总检出率7.03%。其中女性检出率8.95%,男性检出率4.79%,女性检出率高于男性(P〈0.01)。从年龄结构看:50岁~59岁组检出率最高11.73%,其次是18岁~29岁组和60C以上岁组。TSH与血脂相关因素中,男性TSH与尿酸(UA)呈正相关,与载酯蛋白A(APOA)呈负相关。结论:我科个体从业健康体检人员SCH总检出率较上海(6.1%)、南昌地区(6.1%)高;SCH的发生与年龄和性别相关;TSH血浓度对血脂的影响因性别不同而不同。 Objective:To investigate the prevalence of subclinical hypothyroidism(SCH) in independent merchant.Methods: Serum levels of TSH,FT3 and FT4 by chemilumino-immunoassay and lipid profile in 2958 subjects were determined in independent merchant.Results: The overall SCH prevalence was 7.03%.The SCH prevalence was significantly higher in females(8.95%) than in males(4.79%).The relationship between the SCH prevalence in the sex and the age showed that the highest SCH prevalence was in the 50 years old group(11.73%),the followed by 18 years old group(7.42%) and the 60 years old group(7.37%).Serum TSH was closely in postive corelation to plasma UA levels in males(P0.01),serum TSH was closely in nagetive corelation to plasma APOA levels in this group.Conclusion: The SCH prevalence is higher in independent merchant than Shanghai,Nanchang area.The serum TSH levels in famels and mels have a different effect on lipid.
作者 杨秀琴
出处 《中国卫生检验杂志》 CAS 2011年第1期206-207,共2页 Chinese Journal of Health Laboratory Technology
  • 相关文献

参考文献8

二级参考文献87

  • 1毛林华.甲状腺素对亚临床甲减患者血脂及左心室功能的影响[J].实用老年医学,2005,19(1):39-41. 被引量:3
  • 2冯根定 胡兰萍.一种新的非放射性标记的超微量免疫化学分析技术-Serozyme系统IEMA测定血清TSH及临床评价[J].中华流行病学杂志,1997,18(3):63-63.
  • 3Canaris GJ, Manowitz NR, Mayor Get al. The Colorado thyroid disease prevalence study. Arch Intern Med, 2000; 160 (4): 526.
  • 4Walsh JP, Bremner AP, Bulsara MK et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med, 2005; 165 (21) : 2467 -2472.
  • 5Imaizumi M, Akahoshi M, Ichimam S et al. Risk for ischemic heart disease and all - cause mortality in subclinical Hypothyroidism. J Clin Endocri & Metabol, 2004; 89 (7) : 3365 - 3370.
  • 6Rodondi N, Newman AB, Vittinghoff E et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med, 2005; 165 (21) : 2460 - 2466.
  • 7Cappola AR, Fried LP, Arnold AM et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA, 2006; 295 (9): 1033-1041.
  • 8Hak AE, Pols HA, Visser TJ et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med, 2000; 132:270 - 278.
  • 9Coban E, Yazicioglu G, Ozdogan M. Platelet activation in subjects with subclinical hypothyroidism. Med Sci Monit, 2007; 13 (4): CR211-214.
  • 10Canturk Z, Cetinarslan B, Tarkun Iet al. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid, 2003; 13 (10) : 971 - 977.

共引文献139

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部